A joint venture has positioned DSM in a fast-growing Chinese food enzyme market.
Royal DSM N.V. (Heerlen, Netherlands) has entered into a joint venture with a Chinese biotech company to provide food enzyme solutions for China.
DSM’s partner in the project is Yixing Qiancheng Bio-Engineering Company Ltd. (Yixing, China), a specialist in food additives since 1993.
According to DSM, China’s food enzymes market is growing at rates far above the global average.
“This joint venture provides DSM with a strong enzyme operating platform in Chinese and Asian markets,” said Lars Asferg, director of enzyme solutions at DSM Food Specialties. “Food is a local business and you need to be present in your customers markets to create innovative solutions to meet the specific local preferences of our customers. The Yixing enzyme plant will expand the DSM global manufacturing networks on the Asian continent.”
Asferg added that the Yixing plant will be upgraded to meet quality and traceability standards as outlined by DSM’s Quality for Life commitment.
DSM is assuming 85% of shares in the joint venture. Yixing will absorb the remaining 15%.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.